Follow our Journeys
Sharing success stories internal to Duke Capital Partners and external to our portfolio companies.
Pryon Closes $100 Million Series B Round Led by Thomas Tull’s US Innovative Technology Fund
Pryon, a DCP portco, is bringing AI to knowledge management.
Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device
Sparta Biomedical, a DCP portco, was founded around tech developed by Duke faculty
Intel Capital and Khosla Ventures Lead $27M Investment in SiPhox® Health to Transform Health Testing
Silicon Photonic chips developed by SiPhox, a Duke Capital Partners portfolio company, scale access to healthcare
Realtime Robotics Funded an Additional $9.5 Million to Meet Increased Demand for Technology that Transforms Manufacturing
Realtime Robotics, a Duke start-up and Duke Capital Partners portfolio company, was founded by Professor Daniel Sorin (ECE, Pratt).
How a Duke Professor and Two Duke Ph.D.s are Building an AI Drug Discovery Start-Up
Duke Professor Bruce Donald and his former students are combining computer science, structural biology, and an entrepreneurial spirit to design new drugs at Ten63 Therapeutics.
Read More about How a Duke Professor and Two Duke Ph.D.s are Building an AI Drug Discovery Start-Up
Associate Spotlight: Blair Willette
Recent Duke Pharmacology Ph.D. graduate Dr. Blair Willette reflects on her time as a Life Sciences Associate at Duke Capital Partners.